A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 31/35 (2006.01) A61K 31/352 (2006.01) A61K 31/415 (2006.01) A61K 38/20 (2006.01) A61K 38/21 (2006.01) A61K 38/44 (2006.01) A61K 39/02 (2006.01) A61K 39/12 (2006.01) A61K 39/39 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) A61K 35/12 (2006.01)
Patent
CA 2341742
The present invention relates to a method for facilitating activation of T- cells in a patient, comprising: identifying a patient in need of enhanced T- cell activity, administering an effective amount of a T-cell activating composition to the patient, and administering an effective amount of a compound that inhibits the production or release of intercellular reactive oxygen metabolites (ROM) to the patient. The present invention further relates to the use of H2-receptor agonists to augment the effectiveness of vaccines.
Un procédé d'activation des cellules T chez un patient consiste à identifier un patient nécessitant une activité accrue des cellules T, à administrer au patient une quantité efficace d'une composition activant les cellules T, et à administrer au patient une quantité efficace d'un composé qui inhibe la production ou la libération de métabolites d'oxygène réactif intercellulaire (MOR). La présente invention concerne également l'utilisation d'agonistes du récepteur H¿2? pour accroître l'efficacité des vaccins.
Gehlsen Kurt R.
Hellstrand Kristoffer
Hermodsson Svante
Maxim Pharmaceuticals Inc.
Sim & Mcburney
LandOfFree
Activation and protection of t-cells (cd4+ and cd8+) using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activation and protection of t-cells (cd4+ and cd8+) using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activation and protection of t-cells (cd4+ and cd8+) using... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1352325